April 16, 2024
Market Now
Samsung BioLogics bags W17.9b order from US
[DISCLOSURE] Samsung BioLogics (207940) announced on Feb. 22 that it has signed a 17.85 billion won (US$16.48 million) contract manufacturing contract with a US pharmaceutical company.
This amounts to 6.06 percent of its 2016 revenue and the details of the contract will remain undisclosed until Dec. 31, 2019 to protect trade secrets.
By Hwang You-mee (glamazon@heraldcorp.com)
This amounts to 6.06 percent of its 2016 revenue and the details of the contract will remain undisclosed until Dec. 31, 2019 to protect trade secrets.
By Hwang You-mee (glamazon@heraldcorp.com)
